FdaApplication
ANDA 218712
Identifiers
- fda_app_no: ANDA218712
Properties
| Property | Value |
|---|---|
| applicant_name | APPCO PHARMA LLC |
| application_type | ANDA |
| approval_date | 2026-01-20 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| SERTRALINE HYDROCHLORIDE | SERTRALINE HYDROCHLORIDE | EQ 150MG BASE | CAPSULE;ORAL |
| SERTRALINE HYDROCHLORIDE | SERTRALINE HYDROCHLORIDE | EQ 200MG BASE | CAPSULE;ORAL |
2 products